25Sep/13

Novel drug prevents common viral disease in stem-cell transplant patients … – Medical Xpress

Novel drug prevents common viral disease in stem-cell transplant patients
Medical Xpress
A new drug can often prevent a common, sometimes severe viral disease in patients receiving a transplant of donated blood-making stem cells, a clinical trial led by researchers at Dana-Farber Cancer Institute and Brigham and Women’s Hospital indicates.
Cytomegalovirus—a ‘stealth’ pathogen—gains attention in the drug development Nature Medicine blog (blog)
CMX001 reduced cytomegalovirus disease after HSCTHealio

all 5 news articles »

25Sep/13

Inovio's DNA Tech Generates HIV Monoclonal Antibodies – Drug Discovery & Development

Inovio’s DNA Tech Generates HIV Monoclonal Antibodies
Drug Discovery & Development
Inovio Pharmaceuticals’ DNA plasmid technology is capable of generating therapeutic monoclonal antibodies, according to a new study published in Human Vaccines and Immunotherapeutics. In this study in mice, a prototype monoclonal antibody construct 
Inovio Pharmaceuticals Inc (INO): Inovio talks monoclonal antibodies, DNA Seeking Alpha
Biotech Volume Movers: Inovio Pharmaceuticals Inc (NYSEMKT:INO), Geron Market News Call
Did Inovio Pharmaceuticals Inc (NYSEMKT:INO) find a cure for HIV?GSPInsider

all 9 news articles »